Prognostic value of circulating tumor DNA fraction (TF) for patients with metastatic renal cell carcinoma (mRCC).

被引：0
|
作者：
Zurita, Amado J.
Danziger, Natalie
Scott, Takara
Gjoerup, Ole
Zhong, Lei
Tukachinsky, Hanna
Ross, Jeffrey S.
Graf, Ryon
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Fdn Med Inc, Cambridge, MA USA
[3] SUNY Upstate Med Univ, Syracuse, NY USA
[4] Fdn Med Inc, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2024.42.4_suppl.455
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
455
引用
收藏
页码：455 / 455
页数：1
相关论文
共 50 条
  • [1] Circulating tumor DNA sequencing analysis of patients with metastatic renal cell carcinoma (mRCC).
    Zengin, Zeynep Busra
    Dizman, Nazli
    Salgia, Nicholas
    Jones, Jeremy
    Zhang, Jingbo
    Liu, Yunchao
    Xu, Bing
    Li, Fuwei
    Wang, Yan
    Li, Mengjian
    Du, Rong
    Zhou, Ye
    Hsu, Joann
    Salgia, Meghan
    Yang, Lixin
    Pal, Sumanta K.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] Association of circulating tumor DNA (ctDNA) detection in metastatic renal cell carcinoma (mRCC) with tumor burden
    Maia, Manuel Caitano
    Bergerot, Paulo Gustavo
    Dizman, Nazli
    Hsu, Joann
    Jones, Jeremy
    Choueiri, Toni K.
    Sonpavde, Guru
    Lannnan, Richard B.
    Banks, Kimberly
    Pal, Sumanta K.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Tumor burden as an independent prognostic factor in metastatic renal cell carcinoma (mRCC).
    Escudier, Bernard J.
    Iacovelli, Roberto
    Lanoy, Emilie
    Albiges, Laurence
    Fizazi, Karim
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [4] Correlation between depression/anxiety and somatic circulating tumor DNA (ctDNA) alterations in patients with metastatic renal cell carcinoma (mRCC).
    Bergerot, Cristiane Decat
    Bergerot, Paulo Gustavo
    Clark, Karen L.
    Loscalzo, Matthew J.
    Lanman, Richard B.
    Banks, Kimberly
    Pal, Sumanta K.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [5] Prognostic value of baseline circulating tumor DNA (ctDNA) tumor fraction (TF) in metastatic hormone-sensitive prostate cancer (mHSPC)
    Nguyen, Charles B.
    Tsung, Irene
    Lee, Jessica K.
    Pasquina, Lincoln W.
    Kasputis, Amy
    Lovett, Jennie L.
    Graf, Ryon P.
    Cackowski, Frank Cameron
    Heath, Elisabeth I.
    Morgan, Todd Matthew
    Reichert, Zachery R.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Longitudinal Testing of Circulating Tumor DNA in Patients With Metastatic Renal Cell Carcinoma
    Basu, Arnab
    Au, Cherry
    Kommalapati, Ajitha
    Kandala, Hyndavi
    Sudhaman, Sumedha
    Mahmood, Tamara
    Carson, Carcia
    Pajak, Natalia
    Dutta, Punashi
    Calhoun, Mark
    Malhotra, Meenakshi
    Elnaggar, Adam C.
    Liu, Minetta C.
    Ferguson Iii, James
    Peyton, Charles
    Rais-Bahrami, Soroush
    Tan, Alan
    JCO PRECISION ONCOLOGY, 2024, 8
  • [7] Tumor response is an independent prognostic factor in patients (pts) treated for metastatic renal cell carcinoma (mRCC)
    Gruenwald, V.
    Lin, X.
    Kalanovic, D.
    McKay, R.
    Perkins, J.
    Simantov, R.
    Choueiri, T.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S642 - S642
  • [8] Circulating tumor DNA analysis of metastatic renal cell carcinoma
    Zhang, Jingbo
    Liu, Yunchao
    Xu, Bing
    Li, Fuwei
    Wang, Yan
    Li, Mengjian
    Du, Rong
    Zhou, Ye
    Salgia, Meghan
    Yang, Lixin
    Jones, Jeremy O.
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 14 (01) : 1 - 5
  • [9] Cell-free Circulating Tumor DNA (ctDNA) in Metastatic Renal Cell Carcinoma (mRCC): Current Knowledge and Potential Uses
    Hahn, Andrew W.
    Nussenzveig, Roberto H.
    Maughan, Benjamin L.
    Agarwal, Neeraj
    KIDNEY CANCER, 2019, 3 (01) : 7 - 13
  • [10] Detection of circulating tumor DNA in patients with metastatic clear cell renal cell carcinoma.
    Nappi, Lucia
    Bacon, Jack
    Annala, Matti
    Soleimani, Maryam
    Lavoie, Jean-Michel
    Chi, Kim N.
    Wyatt, Alexander William
    Kollmannsberger, Christian K.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345